We next leveraged publicly available (GSE110903) RNA-seq data to further study the effects of genomic inhibition of AR on ASE in MDA-PCa-2b cells, a model for advanced prostate cancer (advPC) bone metastasis cells that express PSA, AR, and are androgen sensitive. Here, AR is linked to prostate carcinoma.